Deuterium Oxide Circadian Rhythm Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for mood disorders and circadian rhythm sleep disorders, such as antidepressant medications and light therapy, face challenges including delayed response times, side effects, and inefficacy in some patients, while existing substances like benzodiazepines and melatonin have limitations due to high abuse potential and sedation side effects.
Innovation Solution
Administration of deuterium oxide, which penetrates the brain's suprachiasmatic nucleus to alter circadian rhythms, providing a rapidly acting, non-addictive, and low-side-effect treatment for depression and anxiety, and addressing circadian rhythm sleep disorders by changing the body's internal clock.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antidepressant medications are used to treat depression, then the treatment can be effective for many patients, but the response time is delayed (two weeks or more) and side effects are problematic
Solution Approach 1:
The patent uses deuterium oxide (D2O) to alter the kinetic parameters of biochemical reactions in the brain. By replacing hydrogen with deuterium in water molecules, the patent exploits the kinetic isotope effect to slow down metabolic reactions, thereby adjusting the timing and duration of neurotransmitter activity to regulate circadian rhythms and treat depression rapidly without the delayed response characteristic of conventional antidepressants.
Solution Approach 2:
The patent replaces the mechanical/pharmacological system of conventional antidepressants (which require weeks to modulate neurotransmitter receptors) with a chronobiological system based deuterium oxide administration. This substitution leverages the natural kinetic isotope effect to directly influence circadian clock mechanisms in the suprachiasmatic nucleus, achieving rapid antidepressant effects through rhythmic regulation rather than gradual receptor adaptation.
2Adaptability or versatility
If conventional antidepressants are administered, then treatment coverage is broad, but dosing precision is difficult to achieve due to variability in absorption and metabolism
Solution Approach 1:
The patent implements a feedback mechanism by using deuterium oxide as an endogenous tracer to measure total body water and brain water content. By administering a known dose of D2O and measuring its dilution in body fluids, the patent can precisely calculate individual total body water volume and estimate brain water content, thereby enabling precise dosing of deuterated compounds based on actual brain water concentration rather than standard weight-based dosing.
Solution Approach 2:
The patent replaces the complex pharmacokinetic system of variable absorption and metabolism with a direct water-based distribution system. Since deuterium oxide distributes uniformly with total body water and crosses the blood-brain barrier, the patent achieves predictable and precise brain concentrations based solely on total body water content, eliminating the variability inherent in conventional drug absorption and metabolic pathways.
3Measurement precision
If blood sampling is performed to determine therapeutic serum level, then accurate measurement is obtained, but the procedure is invasive and troublesome to patients
Solution Approach 1:
The patent makes total body water measurement serve multiple functions: it quantifies the distribution volume for precise dosing calculations, monitors brain water content to estimate drug concentration, and provides a non-invasive alternative to blood sampling. By using deuterium oxide as a universal tracer that distributes throughout all body water compartments, the patent eliminates the need for invasive procedures while maintaining measurement accuracy through simple urine or saliva analysis.
4Reliability
If benzodiazepines are used to treat circadian rhythm sleep disorders, then circadian rhythms are altered, but abuse potential is high and side effects include excess sedation and amnesia
Solution Approach 1:
The patent uses deuterium oxide to alter the kinetic parameters of circadian clock reactions without producing the harmful effects of benzodiazepines. By exploiting the kinetic isotope effect to slow down biochemical reactions in the suprachiasmatic nucleus, the patent achieves circadian rhythm modulation through physiological timing adjustments rather than GABA receptor manipulation, thereby avoiding sedation, amnesia, and abuse potential while maintaining therapeutic effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Deuterium oxide offers a safe, effective, and rapidly acting treatment for mood disorders and circadian rhythm sleep disorders, allowing for precise dosing and non-invasive monitoring, potentially overcoming the limitations of existing treatments by directly influencing the body's circadian rhythms.
Implementation Method 1
Deuterium oxide...diffuses evenly and rapidly throughout the total body water
Data Source
AI summary
Compositions and methods for treating depression, anxiety and/or circadian rhythm sleep disorders using deuterium oxide and various compounds thereof.